{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:59:18Z","timestamp":1792213158430,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1821,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.fertnstert.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T14:42:45Z","timestamp":1494427365000},"page":"1284-1293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Immune modulation treatments\u2014where is\u00a0the evidence?"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-0858","authenticated-orcid":false,"given":"Malene Meisner","family":"Hviid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Macklon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.04.009_bib1","doi-asserted-by":"crossref","first-page":"e013940","DOI":"10.1136\/bmjopen-2016-013940","article-title":"Claims for fertility interventions: a systematic assessment of statements on UK fertility centre websites","volume":"6","author":"Spencer","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14647273.2015.985454","article-title":"British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice","volume":"18","author":"Nardo","year":"2015","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/cimm.1999.1532","article-title":"Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions","volume":"196","author":"Raghupathy","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/dev098","article-title":"First do no harm: uterine natural killer (NK) cells in assisted reproduction","volume":"30","author":"Moffett","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1472-6483(10)90004-7","article-title":"New insights into maternal-fetal interactions at implantation","volume":"2","author":"Chaouat","year":"2001","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aji.12493","article-title":"Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation?","volume":"76","author":"Mekinian","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib8","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/humrep\/dew186","article-title":"Corticosteroid therapy in assisted reproduction\u2014immune suppression is a faulty premise","volume":"31","author":"Robertson","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/humrep\/dep011","article-title":"Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF","volume":"24","author":"Boomsma","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1600-0897.2001.d01-18.x","article-title":"Increased natural killer\u2013cell activity is associated with infertile women","author":"Matsubayashi","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/humrep\/15.5.1163","article-title":"Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion","volume":"15","author":"Emmer","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/humrep\/dep349","article-title":"Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage","volume":"25","author":"King","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jri.2010.07.001","article-title":"Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF","volume":"87","author":"Tuckerman","year":"2010","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib14","first-page":"CD005996","article-title":"Peri-implantation glucocorticoid administration for assisted reproductive technology cycles","author":"Boomsma","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF02066497","article-title":"Successful glucocorticoid treatment for patients with abnormal autoimmunity on in\u00a0vitro fertilization and embryo transfer","volume":"13","author":"Ando","year":"1996","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib16","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/oxfordjournals.humrep.a019454","article-title":"The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization\u2014a randomized study","volume":"11","author":"Bider","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(16)57428-7","article-title":"Low-dose glucocorticoids after in\u00a0vitro fertilization and embryo transfer have no significant effect on pregnancy rate","volume":"63","author":"Moffitt","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.humrep.a136451","article-title":"Prednisolone supplementation to Clomid and\/or gonadotrophin stimulation for in-vitro fertilization\u2014a prospective randomized trial","volume":"1","author":"Kemeter","year":"1986","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1447-0756.1997.tb00874.x","article-title":"The immunotherapy during in\u00a0vitro fertilization and embryo transfer cycles in infertile patients with endometriosis","volume":"23","author":"Kim","year":"1997","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib20","first-page":"889","article-title":"Increasing clinical pregnancy rates after IVF\/ET. Can immunosuppression help?","volume":"41","author":"Mottla","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0015-0282(16)55223-6","article-title":"The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in\u00a0vitro fertilization: a prospective randomized study","volume":"58","author":"Tan","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/humrep\/17.6.1544","article-title":"Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates","volume":"17","author":"Ubaldi","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00404-013-3020-8","article-title":"Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure?","volume":"289","author":"Fawzy","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2310\/7200.2006.023","article-title":"How to randomize","volume":"4","author":"Vickers","year":"2006","journal-title":"J Soc Integr Oncol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib25","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0015-0282(98)00312-4","article-title":"Antibodies to beta2 glycoprotein I are associated with in\u00a0vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study","volume":"70","author":"Stern","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0378(01)00075-4","article-title":"Autoantibody studies of female patients with reproductive failure","volume":"51","author":"Reimand","year":"2001","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9378(89)90524-3","article-title":"Presence of autoantibodies in women with unexplained infertility","volume":"161","author":"Taylor","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0015-0282(16)57425-1","article-title":"The effect of endometriosis, its stage and activity, and of autoantibodies on in\u00a0vitro fertilization and embryo transfer success rates","volume":"63","author":"Dmowski","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib29","first-page":"383","article-title":"Results of prednisolone given to improve the outcome of in\u00a0vitro fertilization-embryo transfer in women with antinuclear antibodies","volume":"50","author":"Taniguchi","year":"2005","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.8755-8920.2000.430107.x","article-title":"Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study","volume":"43","author":"Geva","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3109\/01443615.2012.717988","article-title":"Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnancy in patients undergoing IVF\/ICSI?","volume":"32","author":"Hanevik","year":"2012","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/humrep\/den476","article-title":"Does low-dose aspirin improve pregnancy rate in IVF\/ICSI? A randomized double-blind placebo controlled trial","volume":"24","author":"Dirckx","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in\u00a0vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1023\/A:1026491426423","article-title":"Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study","volume":"17","author":"Urman","year":"2000","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0015-0282(03)00610-1","article-title":"A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in\u00a0vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies","volume":"80","author":"Stern","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib36","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.fertnstert.2004.02.082","article-title":"Low-dose aspirin in a short regimen as standard treatment in in\u00a0vitro fertilization: a randomized, prospective study","volume":"81","author":"Waldenstr\u00f6m","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib37","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/humrep\/dei020","article-title":"Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study","volume":"20","author":"P\u00e4kkil\u00e4","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10815-005-9003-3","article-title":"Does addition of low-dose aspirin and\/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in\u00a0vitro fertilization success? A randomized, prospective, placebo-controlled study","volume":"23","author":"Duvan","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib39","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.08.037","article-title":"Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study","volume":"90","author":"Revelli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib40","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2008.07.1759","article-title":"Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial","volume":"92","author":"Lambers","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib41","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.01.085","article-title":"Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome","volume":"93","author":"V\u00e1rnagy","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib42","first-page":"CD004832","article-title":"Aspirin for in\u00a0vitro fertilisation","author":"Siristatidis","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib43","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humupd\/dmn031","article-title":"The potential role of heparin in assisted conception","volume":"14","author":"Nelson","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib44","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.fertnstert.2010.12.033","article-title":"The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study","volume":"95","author":"Berker","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.rbmo.2011.03.016","article-title":"Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study","volume":"22","author":"Noci","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib46","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/dep086","article-title":"Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial","volume":"24","author":"Urman","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/14647270801995431","article-title":"Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial","volume":"11","author":"Qublan","year":"2008","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-005-9013-1","article-title":"Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in\u00a0vitro fertilization and embryo transfer (IVF)","volume":"23","author":"Clark","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0378(96)00969-2","article-title":"Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in\u00a0vitro in women with recurrent spontaneous abortion","volume":"31","author":"Ruiz","year":"1996","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/aji.12217","article-title":"Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion","volume":"71","author":"Ramos-Medina","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib51","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0015-0282(00)01622-8","article-title":"Treatment of repeated unexplained in\u00a0vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial","volume":"74","author":"Stephenson","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0897.2012.01169.x","article-title":"Intravenous immunoglobulin for repeated IVF failure and unexplained infertility","volume":"68","author":"Virro","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib53","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0897.2011.01018.x","article-title":"Elevated preconception CD56 +16 + and\/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF","volume":"66","author":"Winger","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib54","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/aji.12170","article-title":"Intravenous immunoglobulin treatment for repeated IVF\/ICSI failure and unexplained infertility: a systematic review and a meta-analysis","volume":"70","author":"Li","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0897.2008.00669.x","article-title":"Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF","volume":"61","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib56","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1600-0897.2010.00946.x","article-title":"Degree of TNF-alpha\/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with adalimumab (Humira) and IVIG","volume":"65","author":"Winger","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0897.2012.01179.x","article-title":"Die-off ratio correlates with increased TNF-alpha: IL-10 ratio and decreased IVF success rates correctable with Humira","volume":"68","author":"Winger","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0897.2007.00473.x","article-title":"Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G","volume":"57","author":"Roussev","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2017.04.009_bib59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijgo.2016.06.026","article-title":"Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells","volume":"135","author":"Dakhly","year":"2016","journal-title":"Int J Gynecol Obstet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217303424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217303424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:54:11Z","timestamp":1666508051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028217303424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0015028217303424"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.04.009","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune modulation treatments\u2014where is\u00a0the evidence?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}